Ammonium lactate - Foamix
Alternative Names: Ammonium lactate 12% foam - Foamix; Ammonium lactate emollient foam - Foamix; LactiFoamLatest Information Update: 16 Mar 2020
At a glance
- Originator Foamix
- Class Lactates; Sulfhydryl compounds
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Atopic dermatitis; Dry skin; Ichthyosis; Psoriasis
Highest Development Phases
- Discontinued Atopic dermatitis; Dry skin; Ichthyosis; Psoriasis
Most Recent Events
- 09 Mar 2020 Foamix has been acquired by Menlo Therapeutics
- 05 Jun 2013 Discontinued - Preclinical for Atopic dermatitis in Israel (Topical)
- 05 Jun 2013 Discontinued - Preclinical for Dry-skin in Israel (Topical)